These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28409548)

  • 1. RBMS3 Inhibits the Proliferation and Metastasis of Breast Cancer Cells.
    Yang Y; Quan L; Ling Y
    Oncol Res; 2018 Jan; 26(1):9-15. PubMed ID: 28409548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The RNA binding protein RBMS3 inhibits the metastasis of breast cancer by regulating Twist1 expression.
    Zhu L; Xi PW; Li XX; Sun X; Zhou WB; Xia TS; Shi L; Hu Y; Ding Q; Wei JF
    J Exp Clin Cancer Res; 2019 Feb; 38(1):105. PubMed ID: 30819235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of Homeobox B5 (HOXB5) Inhibits Cell Proliferation, Migration, and Invasion in Non-Small Cell Lung Cancer Cells Through Inactivation of the Wnt/β-Catenin Pathway.
    Zhang B; Li N; Zhang H
    Oncol Res; 2018 Jan; 26(1):37-44. PubMed ID: 28337958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA binding protein RBMS3 is a common EMT effector that modulates triple-negative breast cancer progression via stabilizing PRRX1 mRNA.
    Block CJ; Mitchell AV; Wu L; Glassbrook J; Craig D; Chen W; Dyson G; DeGracia D; Polin L; Ratnam M; Gibson H; Wu G
    Oncogene; 2021 Nov; 40(46):6430-6442. PubMed ID: 34608266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel oncogene TRIM63 promotes cell proliferation and migration via activating Wnt/β-catenin signaling pathway in breast cancer.
    Li K; Pan W; Ma Y; Xu X; Gao Y; He Y; Wei L; Zhang J
    Pathol Res Pract; 2019 Oct; 215(10):152573. PubMed ID: 31399258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RBMS3 delays disc degeneration by inhibiting Wnt/β-catenin signaling pathway.
    Wang JJ; Liu XY; Du W; Liu JQ; Sun B; Zheng YP
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):499-507. PubMed ID: 32016951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RBMS3 at 3p24 inhibits nasopharyngeal carcinoma development via inhibiting cell proliferation, angiogenesis, and inducing apoptosis.
    Chen J; Kwong DL; Zhu CL; Chen LL; Dong SS; Zhang LY; Tian J; Qi CB; Cao TT; Wong AM; Kong KL; Li Y; Liu M; Fu L; Guan XY
    PLoS One; 2012; 7(9):e44636. PubMed ID: 22957092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of eIF3D inhibits breast cancer cell proliferation and invasion through suppressing the Wnt/β-catenin signaling pathway.
    Fan Y; Guo Y
    Int J Clin Exp Pathol; 2015; 8(9):10420-7. PubMed ID: 26617750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down regulation of RNA binding motif, single-stranded interacting protein 3, along with up regulation of nuclear HIF1A correlates with poor prognosis in patients with gastric cancer.
    Wu Y; Yun D; Zhao Y; Wang Y; Sun R; Yan Q; Zhang S; Lu M; Zhang Z; Lu D; Li Y
    Oncotarget; 2017 Jan; 8(1):1262-1277. PubMed ID: 27902480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LHX6 inhibits breast cancer cell proliferation and invasion via repression of the Wnt/β-catenin signaling pathway.
    Hu Z; Xie L
    Mol Med Rep; 2015 Sep; 12(3):4634-4639. PubMed ID: 26129710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-34a Inhibits Breast Cancer Proliferation and Progression by Targeting Wnt1 in Wnt/β-Catenin Signaling Pathway.
    Si W; Li Y; Shao H; Hu R; Wang W; Zhang K; Yang Q
    Am J Med Sci; 2016 Aug; 352(2):191-9. PubMed ID: 27524218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of miR-194-5p inhibits cell proliferation, migration and invasion in breast cancer by regulating the Wnt/β-catenin signaling pathway.
    Yang F; Xiao Z; Zhang S
    Int J Mol Med; 2018 Dec; 42(6):3355-3363. PubMed ID: 30272253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low SFRP1 Expression Correlates with Poor Prognosis and Promotes Cell Invasion by Activating the Wnt/β-Catenin Signaling Pathway in NPC.
    Ren XY; Zhou GQ; Jiang W; Sun Y; Xu YF; Li YQ; Tang XR; Wen X; He QM; Yang XJ; Liu N; Ma J
    Cancer Prev Res (Phila); 2015 Oct; 8(10):968-77. PubMed ID: 26276746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of RBMS3 is associated with poor prognosis in esophageal squamous cell carcinoma.
    Li Y; Chen L; Nie CJ; Zeng TT; Liu H; Mao X; Qin Y; Zhu YH; Fu L; Guan XY
    Cancer Res; 2011 Oct; 71(19):6106-15. PubMed ID: 21844183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of Forkhead Box L1 (FOXL1) Inhibits the Proliferation and Invasion of Breast Cancer Cells.
    Zhong J; Wang H; Yu J; Zhang J; Wang H
    Oncol Res; 2017 Jul; 25(6):959-965. PubMed ID: 27938507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of RBMS3 in Breast Cancer Progression.
    Górnicki T; Lambrinow J; Mrozowska M; Romanowicz H; Smolarz B; Piotrowska A; Gomułkiewicz A; Podhorska-Okołów M; Dzięgiel P; Grzegrzółka J
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor Suppressor Effect of RBMS3 in Breast Cancer.
    Wang C; Wu Y; Liu Y; Pan F; Zeng H; Li X; Yu L
    Technol Cancer Res Treat; 2021; 20():15330338211004921. PubMed ID: 33910421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transposon Mutagenesis Reveals RBMS3 Silencing as a Promoter of Malignant Progression of BRAFV600E-Driven Lung Tumorigenesis.
    Vaishnavi A; Juan J; Jacob M; Stehn C; Gardner EE; Scherzer MT; Schuman S; Van Veen JE; Murphy B; Hackett CS; Dupuy AJ; Chmura SA; van der Weyden L; Newberg JY; Liu A; Mann K; Rust AG; Weiss WA; Kinsey CG; Adams DJ; Grossmann A; Mann MB; McMahon M
    Cancer Res; 2022 Nov; 82(22):4261-4273. PubMed ID: 36112789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin Y regulates the proliferation, migration, and invasion of ovarian cancer cells via Wnt signaling pathway.
    Liu H; Shi H; Fan Q; Sun X
    Tumour Biol; 2016 Aug; 37(8):10161-75. PubMed ID: 26831658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of RBMS3 Confers Platinum Resistance in Epithelial Ovarian Cancer via Activation of miR-126-5p/β-catenin/CBP signaling.
    Wu G; Cao L; Zhu J; Tan Z; Tang M; Li Z; Hu Y; Yu R; Zhang S; Song L; Li J
    Clin Cancer Res; 2019 Feb; 25(3):1022-1035. PubMed ID: 30279231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.